FDA Roundup: September 15, 2023
SILVER SPRING, Md., Sept. 15, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued the draft guidance "Labeling for Biosimilar and Interchangeable Biosimilar Products" and corresponding...
Read more »